Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma
heading
Jueliger, S., Lyons, J., Cannito, S., Pata, I., Pata, P., Školnaja, M. et al.
author
statement of authorship
Simone Jueliger, John Lyons, Sara Cannito, Illar Pata, Pille Pata, Marianna Shkolnaya, Oriana Lo Re, Marion Peyrou, Francesc Villarroya, Valerio Pazienza, Francesca Rappa, Francesco Cappello, Mohammad Azab, Pietro Taverna, and Manlio Vinciguerra
source
Epigenetics
publisher
journal volume number month
vol. 11, 10
year of publication
pages
p. 709-720 : ill
subject term
keyword
decitabine
guadecitabine
hepatocellular carcinoma (HCC)
histone macroH2A1
steatohepatitis
ISSN
1559-2294
notes
Bibliogr.: 45 ref
availibility
Võrguteavik
Open Access
Open Access
scientific publication
teaduspublikatsioon
classifier
category (general)
category (sub)
kvartiil
TTÜ department
TTÜ department code
yt
country
gb
language
inglise
report field
aastar2016y
editor's notes
Pi 040417
Jueliger, S., Lyons, J., Cannito, S., Pata, I., Pata, P., Školnaja, M. et al. Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma // Epigenetics (2016) vol. 11, 10, p. 709-720 : ill.